|Podcasts|September 17, 2018

Bringing Stability to Peptide Mapping

Author(s)Merck

Newsletter

Join the global community of analytical scientists who trust LCGC for insights on the latest techniques, trends, and expert solutions in chromatography.

Subscribe Now!

Related Content

Mass Spectrometry–Driven Strategies for Membrane Protein–Targeted Drug Discovery

ByJohn Chasse

February 2nd 2026

Best of the Week: Antibody–Drug Conjugates, Corneal Proteomics

ByWill Wetzel

January 30th 2026

Isotope Dilution HPLC–MS/MS Analysis of Serum Cotinine Reveals Environmental Tobacco Smoke–Associated PID Risk

ByJohn Chasse

January 30th 2026

Layer-Resolved Corneal Proteomics Enabled by Laser Ablation Sampling and LC–MS/MS

ByJohn Chasse

January 29th 2026

Thermo Fisher Scientific company office in Silicon Valley, high-tech hub of San Francisco Bay Area - Fremont, CA, USA - 2019 | Image Credit: © MichaelVi - stock.adobe.com.

Thermo Fisher and NVIDIA Partner to Expand AI Driven Laboratory Automation

ByKate Jones

January 29th 2026

Bringing Stability to Peptide Mapping

Newsletter

Related Content

Mass Spectrometry–Driven Strategies for Membrane Protein–Targeted Drug Discovery

Best of the Week: Antibody–Drug Conjugates, Corneal Proteomics

Isotope Dilution HPLC–MS/MS Analysis of Serum Cotinine Reveals Environmental Tobacco Smoke–Associated PID Risk

Layer-Resolved Corneal Proteomics Enabled by Laser Ablation Sampling and LC–MS/MS

Thermo Fisher and NVIDIA Partner to Expand AI Driven Laboratory Automation

Trending on LCGC International

Mass Spectrometry–Driven Strategies for Membrane Protein–Targeted Drug Discovery

Thermo Fisher and NVIDIA Partner to Expand AI Driven Laboratory Automation

Ep. 43: An Introduction to Optical Photothermal Infrared (O-PTIR) Spectroscopy

Isotope Dilution HPLC–MS/MS Analysis of Serum Cotinine Reveals Environmental Tobacco Smoke–Associated PID Risk

Best of the Week: Antibody–Drug Conjugates, Corneal Proteomics